Pharmacist-physiotherapist Collaborative Management for Early Knee Osteoarthritis
Recruiting · NCT06681142 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Alberta
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
Osteoarthritis (OA) is a slowly progressive chronic condition that is associated with aging and is characterized as joint pain. Individuals with early-stage OA usually do not seek medical attention. If and when they do, patients more often present to a pharmacy for over-the-counter medications. The investigators want to leverage community pharmacists' accessibility and scope of practice to best support patients with early knee OA. Given there are no disease-modifying treatments for OA, treatment guidelines center on patient education, self-management, and exercise, with medications playing a supporting role. Self-management is an effective strategy that provides a solid foundation for managing this progressive chronic condition and health care professionals like physiotherapists and pharmacists can help with the development and application of these skills.
Who can take part
Inclusion criteria
- regularly experiencing pain, aching, or stiffness in and/or around the knee for at least 1 month
- complete the screening PhIT-OA questionnaire
Exclusion criteria
- Prior total knee replacement or on the waitlist to have your knee replaced
- Knee surgery within the previous 4 months
- History of acute injury to knee within previous 6 months
- Unable to speak and read English
- Unwilling or unable to visit a physiotherapist at a community physiotherapy clinic (specifically the dates and times of the partnering physiotherapy clinic)
- Previous physician-diagnosed inflammatory arthritis (including this list): Rheumatoid arthritis, Psoriatic arthritis, Ankylosing spondylitis, Lupus, Gout
- Physician diagnosed fibromyalgia
- A sudden, severely painful, hot, swollen joint at any time in the past
- History of the following medications: csDMARD or bDMARD or tsDMARD, Immunosuppressive, Allopurinol or febuxostat, Colchicine
- Received a knee joint injection in the past 3 months or have one scheduled in the next 3 months
- Has completed the GLA:D Hip and Knee program at all in the past
Where it is running
1 location listed.
- Mint Health & Drugs Sherwood Park - Sherwood Park, Alberta, Canada